share_log

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga ·  Jan 1 05:05

Gainers

  • Aptorum Gr (NASDAQ:APM) shares rose 252.0% to $4.77 during Tuesday's pre-market session. The company's market cap stands at $26.0 million.
  • Onconetix (NASDAQ:ONCO) stock rose 147.13% to $1.08. The company's market cap stands at $8.9 million.
  • Eyenovia (NASDAQ:EYEN) stock rose 99.2% to $0.23. The company's market cap stands at $25.1 million.
  • Baird Medical Investment (NASDAQ:BDMD) shares moved upwards by 39.99% to $1.47. The market value of their outstanding shares is at $52.5 million.
  • Verastem (NASDAQ:VSTM) shares moved upwards by 33.51% to $4.9. The company's market cap stands at $218.0 million.
  • China SXT Pharmaceuticals (NASDAQ:SXTC) stock rose 26.19% to $0.56. The market value of their outstanding shares is at $2.2 million.

Losers

  • Sangamo Therapeutics (NASDAQ:SGMO) shares decreased by 53.4% to $1.09 during Tuesday's pre-market session. The market value of their outstanding shares is at $227.4 million.
  • Cocrystal Pharma (NASDAQ:COCP) shares declined by 33.54% to $2.16. The market value of their outstanding shares is at $21.9 million.
  • Tiziana Life Sciences (NASDAQ:TLSA) stock decreased by 18.56% to $0.61. The company's market cap stands at $63.3 million.
  • Virpax Pharmaceuticals (NASDAQ:VRPX) stock decreased by 18.21% to $0.37. The market value of their outstanding shares is at $3.0 million.
  • Polyrizon (NASDAQ:PLRZ) stock decreased by 10.65% to $1.93. The market value of their outstanding shares is at $8.0 million.
  • Lexeo Therapeutics (NASDAQ:LXEO) stock fell 9.03% to $5.95. The company's market cap stands at $196.7 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment